Alzamend Neuro, Inc. - ALZN
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$442K
QoQ value delta ($000)
+$95K
(+27.38%)
Implied price effect (QoQ)
-23.45%
Shares
Total shares
245,648
QoQ shares delta
+98,026
(+66.4%)
Total shares held by funds (by quarter)
Market chart (ALZN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q2 2026 data: only 12 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| DRW Securities, LLC | 211 | 116,319 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 50 | 27,506 | 0.0% |
| UBS Group AG | 44 | 24,567 | 0.0% |
| VANGUARD GROUP INC | 39 | 21,620 | 0.0% |
| MORGAN STANLEY | 32 | 18,000 | 0.0% |
| Virtu Financial LLC | 23 | 12,582 | 0.0% |
| XTX Topco Ltd | 22 | 12,470 | 0.0% |
| Clearstead Advisors, LLC | 18 | 10,000 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 2,081 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 43 | 0.0% |
| HARBOR INVESTMENT ADVISORY, LLC | 0 | 1 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 22 | 0.0% |
| BlackRock, Inc. | 0 | 437 | 0.0% |